LANDIS G. MICHAEL (Chief Financial Officer) purchased 1.3% of their position (2.87K shares) of POLARYX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $8.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/20/2026ACC: 0001213900-26-018845
DirectorOfficer· Chief Financial Officer
Since Feb 2026
+2.87K
Net shares
Net buyer
$8.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.87K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.87K
Price / share
$2.79
Trade value
$7.99K
% of position
1.3%
2/18/2026
225.36K→228.22K
Total
Net shares
+2.87K
Net value
$7.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | P · Purchase | +2.87K | $2.79 | $7.99K | 1.3% | 225.36K | 228.22K |
| Total | +2.87K | $7.99K | ||||||
Derivative Transactions0
No derivative transactions reported